where will prima be by friday 3rd?, page-65

I always feel as retail 'investors' we seem to have what amounts to a 'virtual' idea of reality concerning what our company is doing. Combined with bot and chart trading, it makes me see the value of charting and the validity of its underlying logic.

I suspect a lot of people who don't 'believe' its power are like me and lack the mental aptitude to grapple with it. I'm not dumb, but have never composed a graph or tried to analyse one because my brain refuses to get any traction with the simple formulas and ideas required to do so.

Truth is, the prospect of it bores me so badly that I am prepared to lose a lot of money by not doing it - and have done so.

Stupid, really, but what the hell, my brain prefers a narrative style of just crapping on about this and that event - when I realise that the charts are telling people who want to make money how to do so.

Not infallible of course, but it doesn't have to be because it is also flexible and later on the same day they change their mind, without having to waste time 'assessing', what for me at least often seems to prove to be a 'virtual' position derived from 'virtual' information.

Anyhow, to revert to pointlessly crapping on, what the new CEO is doing seems to validate the idea that MR had done what he excelled at and the new guy is better for what needs to be done now.

As for the price, well crypto and the Dubai thing were second strings that gave some price support and they have been removed.

The Dubai thing seemed to involve a risk of introducing a dangerous and counter-productive 'snake-oil' flavour to Cvac, to me, given that any reports would not be statisticaly valid and now we learn the sums on it being profitable were 'immature' and/or thwarted by production/export hurdles and that provision of other PRR services would not be sufficient compensation.

I conclude these are the reasons for the drop although again to me, Cvac was always the main game, although I guess oral gardisil is still chugging along somewhere. Be nice to have it up if they decide to immunise the male population as well.

Still, investor access in Germany and USA provide a chance for a different impetus when the 11b results are published (not to mention their own 'wicked' stock traders having a go prompting our own TA-monsters to get pumping again).

cheers,

Misters